1. Home
  2. ZKIN vs GANX Comparison

ZKIN vs GANX Comparison

Compare ZKIN & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZK International Group Co. Ltd

ZKIN

ZK International Group Co. Ltd

HOLD

Current Price

$1.42

Market Cap

84.8M

Sector

Industrials

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.98

Market Cap

78.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZKIN
GANX
Founded
2015
2017
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.8M
78.2M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
ZKIN
GANX
Price
$1.42
$1.98
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
7.1K
560.0K
Earning Date
09-29-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.46
EPS
N/A
N/A
Revenue
N/A
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$1.41
52 Week High
$3.11
$4.34

Technical Indicators

Market Signals
Indicator
ZKIN
GANX
Relative Strength Index (RSI) 49.67 56.38
Support Level $1.37 $1.65
Resistance Level $1.58 $2.11
Average True Range (ATR) 0.14 0.13
MACD 0.00 0.03
Stochastic Oscillator 54.72 83.65

Price Performance

Historical Comparison
ZKIN
GANX

About ZKIN ZK International Group Co. Ltd

ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: